Development of a Specific Variant of Patient Benefit Index (PBI) Assessing Patient Needs, Goals and Benefits in Rosacea Treatment.

Matthias Augustin Rachel Sommer Christine Blome Natalia Kirsten Anna K Langenbruch

Published in: Patient preference and adherence (2023)

The PBI-RO shows satisfying internal consistency and construct validity. It offers the option of a patient-weighted evaluation of the therapeutic benefit of rosacea therapy and may add to more stringent goal orientation in therapy.

Keyphrases

case report
stem cells
contrast enhanced
cell therapy
combination therapy
perovskite solar cells